These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 15473953)

  • 1. Overview of interleukin-2 function, production and clinical applications.
    Gaffen SL; Liu KD
    Cytokine; 2004 Nov; 28(3):109-23. PubMed ID: 15473953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The crucial role of IL-2/IL-2RA-mediated immune regulation in the pathogenesis of type 1 diabetes, an evidence coming from genetic and animal model studies.
    Chistiakov DA; Voronova NV; Chistiakov PA
    Immunol Lett; 2008 Jun; 118(1):1-5. PubMed ID: 18417224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose recombinant interleukin-2 therapy: rationale and potential clinical applications.
    Caligiuri MA
    Semin Oncol; 1993 Dec; 20(6 Suppl 9):3-10. PubMed ID: 8284689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological properties of interleukin 2 and its role in pathogenesis of selected diseases--a review.
    Olejniczak K; Kasprzak A
    Med Sci Monit; 2008 Oct; 14(10):RA179-89. PubMed ID: 18830208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A function for interleukin 2 in Foxp3-expressing regulatory T cells.
    Fontenot JD; Rasmussen JP; Gavin MA; Rudensky AY
    Nat Immunol; 2005 Nov; 6(11):1142-51. PubMed ID: 16227984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early immune response and regulation of IL-2 receptor subunits.
    Hughes-Fulford M; Sugano E; Schopper T; Li CF; Boonyaratanakornkit JB; Cogoli A
    Cell Signal; 2005 Sep; 17(9):1111-24. PubMed ID: 15993752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-2: from T cell growth and homeostasis to immune reconstitution of HIV patients.
    Kryworuchko M; Thèze J
    Vitam Horm; 2006; 74():531-47. PubMed ID: 17027529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination nonviral interleukin-2 gene immunotherapy for head and neck cancer: from bench top to bedside.
    O'Malley BW; Li D; McQuone SJ; Ralston R
    Laryngoscope; 2005 Mar; 115(3):391-404. PubMed ID: 15744147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. WSX-1 over-expression in CD4(+) T cells leads to hyperproliferation and cytokine hyperproduction in response to TCR stimulation.
    Takeda A; Hamano S; Shiraishi H; Yoshimura T; Ogata H; Ishii K; Ishibashi T; Yoshimura A; Yoshida H
    Int Immunol; 2005 Jul; 17(7):889-97. PubMed ID: 15908443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of interleukin-2 gene transcription: a paradigm for inducible, tissue-specific gene expression.
    Bunting K; Wang J; Shannon MF
    Vitam Horm; 2006; 74():105-45. PubMed ID: 17027513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The IL-17 cytokine family.
    Gaffen SL; Kramer JM; Yu JJ; Shen F
    Vitam Horm; 2006; 74():255-82. PubMed ID: 17027518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of IL-2 in homeostasis of regulatory T cells: the IL-2 cycle.
    Yarkoni S; Kaminitz A; Sagiv Y; Yaniv I; Askenasy N
    Bioessays; 2008 Sep; 30(9):875-88. PubMed ID: 18693266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of CD4+CD25+ regulatory T cell activity: it takes (IL-)two to tango.
    Scheffold A; Hühn J; Höfer T
    Eur J Immunol; 2005 May; 35(5):1336-41. PubMed ID: 15827965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute CD4+ T lymphocyte-dependent interleukin-1-driven arthritis selectively requires interleukin-2 and interleukin-4, joint macrophages, granulocyte-macrophage colony-stimulating factor, interleukin-6, and leukemia inhibitory factor.
    Lawlor KE; Wong PK; Campbell IK; van Rooijen N; Wicks IP
    Arthritis Rheum; 2005 Dec; 52(12):3749-54. PubMed ID: 16320325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The regulatory, inflammatory, and T cell programming roles of interleukin-2 (IL-2).
    Lan RY; Selmi C; Gershwin ME
    J Autoimmun; 2008 Aug; 31(1):7-12. PubMed ID: 18442895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The roles of interleukin-15 receptor alpha: trans-presentation, receptor component, or both?
    Schluns KS; Stoklasek T; Lefrançois L
    Int J Biochem Cell Biol; 2005 Aug; 37(8):1567-71. PubMed ID: 15896666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signaling through the murine T cell receptor induces IL-17 production in the absence of costimulation, IL-23 or dendritic cells.
    Liu XK; Clements JL; Gaffen SL
    Mol Cells; 2005 Dec; 20(3):339-47. PubMed ID: 16404147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control of Foxp3+ CD25+CD4+ regulatory cell activation and function by dendritic cells.
    Fehérvári Z; Sakaguchi S
    Int Immunol; 2004 Dec; 16(12):1769-80. PubMed ID: 15520045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fusokine interleukin-2/interleukin-18, a novel potent innate and adaptive immune stimulator with decreased toxicity.
    Acres B; Gantzer M; Remy C; Futin N; Accart N; Chaloin O; Hoebeke J; Balloul JM; Paul S
    Cancer Res; 2005 Oct; 65(20):9536-46. PubMed ID: 16230419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin 5 in the link between the innate and acquired immune response.
    Takatsu K; Kouro T; Nagai Y
    Adv Immunol; 2009; 101():191-236. PubMed ID: 19231596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.